Comparative Effectiveness Research and Personalized Medicine: Catalyzing or Colliding?

By Epstein Robert S.   Teagarden J. Russell  

PharmacoEconomics, Vol. 28, Iss. 10, 2010-10 ,pp. : 905-913

Adis International

Access to resources Recommend Favorite

Economic and Cost-Effectiveness Considerations for Pharmacogenetics Tests: An Integral Part of Translational Research and Innovation Uptake in Personalized Medicine

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 4, 2009-12 ,pp. : 284-296

Bentham Science Publishers

Access to resources Recommend Favorite

Conference Scene: Pharmacogenomics: paving the path to personalized medicine

By Patrinos George P   Innocenti Federico  

Pharmacogenomics, Vol. 11, Iss. 2, 2010-02 ,pp. : 141-146

Future Medicine

Access to resources Recommend Favorite

Editorial (Personalized Medicine in Developing Countries: A Roadmap to Personalized Innovation)

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 3, 2011-01 ,pp. : 156-158

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Effectiveness Regulations and Pharmaceutical Innovation

By Vernon John A.   Golec Joseph H.  

PharmacoEconomics, Vol. 28, Iss. 10, 2010-10 ,pp. : 877-887

Adis International

Access to resources Recommend Favorite